Vapocoolant (Pain Ease Medium Stream) for Intravenous Lines in Emergency Department Patients (NCT01670487) | Clinical Trial Compass
CompletedNot Applicable
Vapocoolant (Pain Ease Medium Stream) for Intravenous Lines in Emergency Department Patients
United States300 participantsStarted 2012-10
Plain-language summary
To determine the efficacy and safety of vapocoolant stream (Pain Ease Medium Stream ) in decreasing the pain of intravenous cannulation.
To compare vapocoolant stream (Pain Ease medium Stream) with control (e.g. sterile water) stream.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients needing intravenous cannulation
* Adults age 18 years equal or greater than.
* Stable patient
* Mentally competent patient able to understand the consent form
Exclusion Criteria:
* Patients with any allergies to the spray components ( e.g.1,1,3,3, pentafluoropropane or 1,1,1,2 tetrafluoroethane )
* Critically ill or unstable patient (e.g. sepsis or shock)
* Infants and children of age , \<18 years.
* Pregnant
* Intravenous cannulation site located in area of compromised blood supply. (ex: patients with Peripheral Vascular Disease , Raynaud's disease, gangrene, Buerger's disease)
* Intravenous cannulation site located in area of insensitive skin; such as , patients with a peripheral neuropathy including diabetic neuropathy.
* Patient intolerant of cold or with hypersensitivity to the cold.
* Patient unable or unwilling to give consent.
What they're measuring
1
Pain Score on the Numeric Rating Scale (NRS)
Timeframe: pain of intravenous catheter placement.